生物标志物
2019年冠状病毒病(COVID-19)
疾病
内皮功能障碍
疾病严重程度
流式细胞术
医学
病态的
免疫学
胃肠病学
生物
内科学
传染病(医学专业)
生物化学
作者
Xiaofeng Liu,Lin Hua,Jinshen Chu,Wei Zhou,Fangtinghui Jiang,Lu Wang,Fanglin Xu,Mingjiao Liu,Jianbang Shi,Guohui Xue
标识
DOI:10.1016/j.intimp.2024.111788
摘要
Circulating Tang cell count is significantly reduced in patients with COVID-19 and is correlated with disease severity and prognosis. The Tang cell count is an important potential biomarker for COVID-19 clinical management. Additionally, these findings provide insight into the pathological features of COVID-19 endothelial injury and provide new directions for treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI